Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Submitted by
admin
on May 3, 2016 - 10:09am
Source:
Bizjournals.com
News Tags:
Merrimack Pharmaceuticals
Onivyde
pancreatic cancer
Headline:
Sales of Merrimack’s new pancreatic cancer drug top $11M in Q1
Do Not Allow Advertisers to Use My Personal information
